Skip to main content
. 2023 May;52(5):880–891. doi: 10.18502/ijph.v52i5.12705

Table 1:

Summary of included studies

Reference Location (language) Participant characteristics Intervention program Baduanjin training Outcome measured Adverse event; follow-up


Sample size (attrition rate) Mean age or age range Frequency (weekly) Time (min) Duration (months)
27 China (Chinese) 104 40–70 EG: Baduanjin/CG: Provide education on basic knowledge of hypertension 3 20 12 BP↓, BMI↓, WHR↓ No
30 China (Chinese) 116 53.27±10.67 EG: Baduanjin/CG: no intervention N N 6 FPG↓ No
26 China (Chinese) 39 60–69 EG: Baduanjin/CG: no intervention 5 40–50 3 Lipid parameters: TG↓, LDL↓, HDL↑ No
23 China (Chinese) 23 41±5.61 EG: Baduanjin/CG: no intervention 5 50–60 3 WC↓, HDL↑, LDL↓ No
24 China (Chinese) 49 63±6.35 EG: Baduanjin/CG: no intervention 5–7 50 18 Lipid parameters: TG↓, TC↓, HDL↓, LDL↓ No
25 China (English) 170 50–57 EG: Baduanjin/CG: no intervention 3 30 6 FGB↓, TG↓, WHR↓, No
28 China (Chinese) 35 57.2±5.4 EG: Baduanjin/CG: no intervention 6 90 6 Lipid parameters: FPG↓, TG↓, HbA1c↓, HDL↑, WHR↓ No
29 China (English) 110 20–59 EG: Baduanjin/CG: no intervention 3 30–60 4 Lipid parameters: TC↓, TG↓, HDL↑, LDL↓ No

EG, experimental group; CG, control group; BP, blood pressure; BMI, body mass index; WHR, waist-to-hip ratio; FPG, fasting plasma glucose; TG, triglycerides; LDL, low-density lipoprotein; HDL, high-density lipoprotein; WC, white cells; TC, total cholesterol; HbA1c, hemoglobin A1c